Oramed Pharma (ORMP)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 05-2014 | 02-2014 | 11-2013 | 08-2013 | 05-2013 | |
| Operating Expenses | 1,903 | 1,186 | 1,168 | 0 | 1,335 |
| Operating Income | -1,903 | -1,186 | -1,168 | N/A | -1,335 |
| Interest Expense | 4 | 3 | 2 | 0 | 6 |
| Other Income | 79 | 74 | 46 | 0 | 85 |
| Pre-tax Income | -1,828 | -1,115 | -1,124 | 0 | -1,256 |
| Net Income Continuous | -1,828 | -1,115 | -1,124 | N/A | -1,256 |
| Net Income | $-1,828 | $-1,115 | $-1,124 | $N/A | $-1,256 |
| EPS Basic Total Ops | -0.18 | -0.12 | -0.14 | N/A | -0.17 |
| EPS Basic Continuous Ops | -0.18 | -0.12 | -0.14 | N/A | -0.17 |
| EPS Diluted Total Ops | -0.18 | -0.12 | -0.14 | N/A | -0.17 |
| EPS Diluted Continuous Ops | -0.18 | -0.12 | -0.14 | N/A | -0.17 |
| EBITDA(a) | $-1,902 | $-1,183 | $-1,165 | $N/A | $-1,334 |